Abstract
Chemotaxis enhances the fitness of Salmonella enterica serotype Typhimurium (S. Typhimurium) during colitis. However, the chemotaxis receptors conferring this fitness advantage and their cognate signals generated during inflammation remain unknown. Here we identify respiratory electron acceptors that are generated in the intestinal lumen as by-products of the host inflammatory response as in vivo signals for methyl-accepting chemotaxis proteins (MCPs). Three MCPs, including Trg, Tsr and Aer, enhanced the fitness of S. Typhimurium in a mouse colitis model. Aer mediated chemotaxis towards electron acceptors (energy taxis) in vitro and required tetrathionate respiration to confer a fitness advantage in vivo. Tsr mediated energy taxis towards nitrate but not towards tetrathionate in vitro and required nitrate respiration to confer a fitness advantage in vivo. These data suggest that the energy taxis receptors Tsr and Aer respond to distinct in vivo signals to confer a fitness advantage upon S. Typhimurium during inflammation by enabling this facultative anaerobic pathogen to seek out favorable spatial niches containing host-derived electron acceptors that boost its luminal growth.
Author Summary
The ability to thrive in the inflamed gut is crucial for Salmonella serotypes to ensure their transmission to a new host. Salmonella serotypes can use alternative electron acceptors that become available during colitis to support their growth by anaerobic respiration, therefore giving the pathogen an advantage over the fermenting microbiota. While it is known that S. Typhimurium benefits from chemotaxis and motility during colitis, the chemotaxis signals the pathogen detects in vivo have not been elucidated. Here we demonstrate that during intestinal inflammation, S. Typhimurium is able to seek energetically favorable niches by detecting the presence of nitrate and tetrathionate, two respiratory electron acceptors that are generated as by-products of the host inflammatory response. Through this mechanism, energy taxis provides a fitness advantage for S. Typhimurium, and likely other facultative anaerobic bacteria, during in vivo growth in the intestinal lumen.
Introduction
The enteric pathogen S. Typhimurium uses its virulence factors, two type III secretion systems (T3SS-1 and T3SS-2), to trigger acute intestinal inflammation [1]. Interestingly, the pathogen can benefit from the host inflammatory response, as indicated by its enhanced luminal growth during colitis [2], [3]. The resulting bloom of S. Typhimurium in the lumen of the inflamed gut enhances its rate of transmission [4]. However, the properties that enhance the fitness of S. Typhimurium during colitis remain incompletely understood.
Flagella-mediated motility is required for efficient growth of S. Typhimurium in the lumen of the inflamed intestine [5], but not in the absence of intestinal inflammation [6], suggesting that the inflammatory host response creates an environment that favors the growth of motile bacteria. The fitness advantage conferred by flagella in the gut is dependent on chemotaxis [6], a property that is predicted to enable S. Typhimurium to seek out favorable metabolic niches. It has been proposed that motility and chemotaxis enable S. Typhimurium to migrate towards complex polysaccharides available for fermentation. Galactose residues are present in high abundance at the cecal mucosa [6] and might attract S. Typhimurium through Trg, a methyl-accepting chemotaxis protein (MCP) that senses galactose and ribose [7], [8], [9]. Chemotaxis is required for S. Typhimurium to get close to the mucosal surface and it has been hypothesized that a concentration gradient of galactose residues might be a possible chemotactic cue that attracts S. Typhimurium towards the intestinal epithelium [6]. However, there is currently no direct evidence to support the proposition that chemotaxis towards fermentable sugars allows S. Typhimurium to enhance its growth during intestinal inflammation. Mucus production in the gut is raised as part of the mucosal defense against S. Typhimurium infection [6], [10], which is consistent with the idea that the availability of fermentable sugars becomes elevated during infection. On the other hand, mucus production is not abrogated in the absence of intestinal inflammation. Furthermore, no chemotactic signals that are absent in the non-inflamed gut, but generated during inflammation have been identified.
We thus reasoned that further investigation into the mechanisms by which chemotaxis enhances the fitness of S. Typhimurium during colitis was warranted. To this end, we determined how mutations in genes encoding different MCPs affect growth in the inflamed intestine and performed follow-up studies to elucidate the mechanisms by which chemotaxis confers a growth advantage during intestinal inflammation.
Results
Trg, Aer and Tsr confer a competitive advantage in the mouse colitis model
We used the mouse colitis model [11] to investigate why chemotaxis provides an advantage in the environment of the inflamed gut. In this model, mice are inoculated with streptomycin one day prior to infection with S. Typhimurium. Preconditioning with streptomycin disrupts the resident microbiota and allows S. Typhimurium to elicit acute cecal inflammation, which is an animal model for human gastroenteritis (reviewed in [12]). We reasoned that a first step in elucidating the mechanism by which chemotaxis increases the fitness of S. Typhimurium during inflammation would be to determine which MCP(s) confer(s) a luminal growth advantage in the mouse colitis model. To this end we generated S. Typhimurium strains carrying mutations in mcpA (FR37), mcpB (FR36), mcpC (FR35), trg (FR42), aer (FR5) or tsr (FR4). As a positive control, we included a chemotaxis-deficient S. Typhimurium cheY mutant (FR13), which lacks a core chemotaxis component that is essential for signal transduction from MCPs to the flagellar apparatus. Each mutant was tested for its ability to compete with wild-type S. Typhimurium (IR715) for luminal growth in the mouse colitis model (competitive infection assay).
Infection of streptomycin pre-treated mice with the S. Typhimurium wild type (IR715) and one of the above mutants resulted in acute cecal inflammation (Fig. S1) and markedly increased cecal mRNA levels of the Kc and Nos2 genes (Fig. 1A). Kc and Nos2 encode the inflammatory markers keratinocyte-derived cytokine (KC) and inducible nitric oxide synthase (iNOS), respectively. Wild-type S. Typhimurium (IR715) was recovered in significantly higher numbers (P<0.05) from the colon contents than a chemotaxis-deficient cheY mutant (FR13) four days after infection (Fig. 1B), which confirmed previous observations in this model [6]. Consistent with the prediction that chemotaxis towards galactose residues might enhance the fitness of S. Typhimurium in the inflamed gut [6], the trg mutant (FR42) was recovered in lower numbers than the wild type. In contrast, mutations in mcpA, mcpB or mcpC did not reduce the fitness of S. Typhimurium (Fig. 1B). Remarkably, the S. Typhimurium wild type (IR715) was recovered in significantly (P<0.05) higher numbers from colon contents than an aer mutant (FR5) or a tsr mutant (FR4) (Fig. 1B), which identified Tsr and Aer as two new MCPs required for luminal growth during colitis. The growth advantage of wild-type S. Typhimurium (IR715) over an aer tsr mutant (FR6) was not significantly greater than that over a tsr mutant (FR4).
In S. Typhimurium, aer is located upstream of mcpC, a gene encoding a MCP that is absent from Escherichia coli [13], [14] (Fig. S2A), thereby raising the possibility that an insertion in aer could be polar on expression of the downstream mcpC gene. However, inactivation of aer did not alter mcpC mRNA levels in vitro (Fig. S2B), which made it unlikely that polar effects on mcpC could account for the phenotype of the aer mutant (FR5) in the mouse colitis model (Fig. 1B). Mutational inactivation of mcpC did not reduce fitness (Fig. 1B), suggesting that Aer, but not McpC, provides a competitive luminal growth advantage in the mouse colitis model. Furthermore, we cloned the aer gene under the control of its native promoter on a low-copy number plasmid (pFR5) and introduced this plasmid into the aer mutant. Streptomycin pre-treated mice were infected with an equal mixture of the aer mutant carrying a control vector (pWSK129) and an aer mutant complemented with the cloned aer gene cloned on pFR5. The complemented aer mutant (aer[pFR5]) was recovered in significantly (P<0.05) higher numbers from colon contents than the aer mutant carrying a control vector (aer[pWSK129]) (Fig. 1B), thereby providing strong support for the idea that Aer confers a growth benefit in the mouse colitis model.
S. Typhimurium causes intestinal inflammation by using T3SS-1 for epithelial invasion and T3SS-2 for macrophage survival [1]. Inactivation of T3SS-1 (through a mutation in invA) and T3SS-2 (through a mutation in spiB) renders S. Typhimurium unable to trigger gut inflammation in the mouse colitis model [10]. To investigate whether migration towards galactose residues would confer a luminal growth advantage in the absence of intestinal inflammation, streptomycin pre-treated mice were infected with an equal mixture of an invA spiB mutant (SPN452) and an invA spiB trg mutant (FR43). Mice infected with this mixture did not exhibit elevated expression of inflammatory markers (Fig. 1A) and the invA spiB trg mutant was recovered in lower numbers than the invA spiB mutant (Fig. 1B), suggesting that Trg conferred a luminal growth advantage in the absence of intestinal inflammation. To determine whether the aer gene and the tsr gene conferred a fitness advantage in the absence of intestinal inflammation, streptomycin pre-treated mice were infected with an equal mixture of an invA spiB mutant (SPN452) and an invA spiB aer mutant (FR11) or an invA spiB mutant (SPN452) and an invA spiB tsr mutant (FR10). Mice infected with these mixtures neither developed intestinal pathology (Fig. S1) nor exhibited elevated expression of inflammatory markers (Fig. 1A). An equal recovery of both strains from colon contents (Fig. 1B) suggested that neither Aer nor Tsr boosted luminal growth of S. Typhimurium in the absence of intestinal inflammation.
To confirm that equal recovery of an invA spiB mutant and an invA spiB aer mutant from mice was due to lack of inflammation, we performed an additional experiment in which inflammation was restored by adding wild-type S. Typhimurium. To this end, streptomycin pre-treated mice were infected with a mixture of the S. Typhimurium wild type (ATCC14028), an invA spiB mutant (SPN452) and an invA spiB aer mutant (FR11). Mice infected with this mixture developed acute intestinal inflammation, as indicated by elevated expression of inflammatory markers (Fig. 1A). The invA spiB mutant was recovered in higher numbers than the invA spiB aer mutant (Fig. 1B), suggesting that inflammation induced by the S. Typhimurium wild type generated an environment in which the aer gene conferred a fitness advantage upon the invA spiB mutant. Similar results were obtained when mice were infected with the S. Typhimurium wild type (ATCC14028), an invA spiB mutant (SPN452) and an invA spiB tsr mutant (FR10) (Fig. 1A and 1B). Collectively, these data supported the working hypothesis that signals generated by the host inflammatory response are detected through Aer and Tsr, thereby enabling S. Typhimurium to migrate towards favorable luminal niches to boost its growth. However, the nature of these signals remained obscure.
Aer mediates energy taxis towards tetrathionate
Enhanced luminal growth of S. Typhimurium during colitis has been linked to the transmigration of neutrophils into the intestinal lumen [15]. Neutrophils release reactive oxygen species (ROS) in an attempt to kill bacteria. A by-product of releasing ROS is the oxidation of endogenous sulfur compounds, such as thiosulfate (S2O3 2−) generated by the colonic epithelium [16], [17], to tetrathionate (S4O6 2−) [18]. Since tetrathionate becomes available only during inflammation [18], we investigated whether this compound could serve as a signal for Aer and/or Tsr during colitis. We tested this hypothesis using the motility plate assay, in which formation of a halo by migration of S. Typhimurium from a point of inoculation into the surrounding motility agar was measured after anaerobic incubation for 6.5 hours. Halo formation was not observed with non-motile (flgK mutant, SW215) or chemotaxis-deficient (cheY mutant, FR13) strains. The tsr mutant (FR4) formed halos with significantly (P<0.05) reduced diameter compared to those produced by the S. Typhimurium wild type (IR715) both in the presence or in the absence of tetrathionate (Fig. S3), suggesting that Tsr responded to signals other than (or in addition to) tetrathionate in this assay. In contrast, the wild type (IR715) formed halos with a significantly (P<0.05) larger diameter than an aer mutant (FR5) when tetrathionate was present in the motility agar, but not when tetrathionate was absent (Fig. S3A and S3B). Anaerobic growth in LB broth inoculated with the wild type (IR715) and an aer mutant (FR5) or the wild type and a tsr mutant (FR4) indicated that inactivation of these chemotaxis receptors did not produce a growth defect (Fig. S3B). These data supported the idea that Aer mediates chemotaxis towards tetrathionate.
Since tetrathionate is not known to bind Aer directly, we were interested in the mechanism by which Aer could detect this compound. The ttrBCA gene cluster encodes a tetrathionate reductase that enables S. Typhimurium to oxidize NADH/H+ by transferring electrons from this donor through the electron transport chain to the terminal electron acceptor tetrathionate (tetrathionate respiration) [19]. Aer possesses a flavin adenine dinucleotide (FAD)-binding domain that enables this MCP to respond to changes in the redox status of the bacterial cell [20], [21], a process termed energy taxis [22]. We thus reasoned that by reducing tetrathionate, the TtrBCA tetrathionate reductase might change the redox status of the bacterial cell, thereby generating a signal that is sensed by Aer. This hypothesis would predict that a tetrathionate respiration-deficient mutant would be unable to migrate towards tetrathionate by Aer-mediated energy taxis. To test this prediction, we assessed the ability of a tetrathionate respiration-deficient (ttrA) mutant to migrate towards tetrathionate in the motility plate assay. Consistent with our hypothesis, a ttrA mutant (SW661) formed halos with a significantly (P<0.05) smaller diameter than the wild type (IR715) when tetrathionate was present in the motility agar, but not when this terminal electron acceptor was absent (Fig. S3A and S3B).
To further investigate whether tetrathionate respiration serves as a signal for Aer, we used the capillary assay [23], in which a glass capillary was submerged in a reservoir containing an equal mixture of two S. Typhimurium strains and migration into the capillary was measured after a 45 minute anaerobic incubation. In the absence of tetrathionate, the wild type (IR715) and an aer mutant (FR5) were recovered in equal numbers from the capillary. In contrast, the wild type was recovered in significantly higher numbers when the capillary contained tetrathionate (Fig. 2A and Table S1). Introduction of the cloned aer gene (pFR5) into the aer mutant resulted in increased recovery from a capillary containing tetrathionate. These data provided further support for the idea that Aer mediates chemotaxis towards tetrathionate. When a capillary containing tetrathionate was submerged in a reservoir filled with a ttrA mutant and a ttrA aer mutant, both strains were recovered in equal numbers (Fig. 2A), suggesting that Aer-mediated chemotaxis towards tetrathionate was dependent on tetrathionate respiration in vitro. Consistent with the fact that genes for the utilization of inferior electron acceptors are repressed in the presence of oxygen [24], we did not observe energy taxis towards tetrathionate when the assay was repeated under aerobic conditions (Fig. 2A). To test the idea that Aer detects tetrathionate by sensing changes in the redox status of the cell, we generated a strain carrying a point mutation in the aer open reading frame (C65T) leading to an amino acid substitution (S22F) that inactivates the FAD-binding domain of Aer (aerS22F mutant, FR47) [25]. Under anaerobic conditions, the S. Typhimurium wild type was recovered in significantly higher numbers than the aerS22F mutant from a tetrathionate-containing capillary (Fig. 2A), which supported the idea that Aer senses tetrathionate by measuring the redox status of the cell. Interestingly, the wild type (IR715) and a tsr mutant (FR4) were recovered in equal numbers from a capillary containing tetrathionate (Fig. 2A), suggesting that Tsr does not mediate taxis towards tetrathionate in vitro.
To investigate whether the fitness advantage conferred by the aer and/or tsr genes was dependent on the ability of S. Typhimurium to perform tetrathionate respiration in vivo, we infected groups of streptomycin pre-treated mice with equal mixtures of either a tetrathionate respiration-deficient mutant (ttrA mutant, SW661) and a ttrA aer mutant (FR9) or a ttrA mutant (SW661) and a ttrA tsr mutant (FR8). The ttrA mutant (SW661) outcompeted the ttrA tsr mutant (FR8) (Fig. 1B), suggesting that the fitness advantage conferred by Tsr was independent of tetrathionate respiration. In contrast, the fitness advantage conferred by Aer was abrogated during competition of the ttrA mutant (SW661) with the ttrA aer mutant (FR9). These data suggested that the ability of S. Typhimurium to utilize tetrathionate as an electron acceptor was required to see a benefit of Aer during growth in the inflamed gut. Finally, the S. Typhimurium wild type outcompeted the aerS22F mutant (FR47) in streptomycin pre-treated mice, suggesting that redox sensing by Aer conferred a fitness advantage in the mouse colitis model.
To rule out that our phenotype was a result of disrupting the microbiota by treating mice with streptomycin, we infected genetically resistant (CBA) mice in the absence of streptomycin (mouse typhoid model). In this model, mice develop cecal inflammation by day 10 after infection [26]. Mice were infected with an equal mixture of the S. Typhimurium wild type (IR715) and an aer mutant (FR5) or with an equal mixture of a ttrA mutant (SW661) and a ttrA aer mutant (FR9). Wild-type S. Typhimurium was recovered in significantly higher numbers (P<0.05) from colon contents than an aer mutant at 10 days and 28 days after infection (Fig. S4). At 10 days after infection, the fitness advantage conferred by Aer was significantly (P<0.05) reduced during competition of the ttrA mutant with the ttrA aer mutant. By day 28 after infection, strains defective for tetrathionate respiration (i.e. the ttrA mutant and the ttrA aer mutant) were no longer recovered from colon contents.
Tsr mediates energy taxis towards nitrate
Inflammation induces expression of inducible nitric oxide synthase (iNOS), an enzyme catalyzing the production of nitric oxide (NO). Nitric oxide can react with ROS to generate nitrate (NO3 −), an electron acceptor that becomes available during inflammation [26]. Unlike tetrathionate reductases, nitrate reductases transport protons by scalar chemistry [24]. Since Tsr is proposed to sense changes in the proton-motive force [20], we reasoned that this MCP might sense nitrate during colitis. We used the capillary assay under anaerobic conditions to test this idea. In the absence of nitrate, the wild type (IR715) and a tsr mutant (FR4) were recovered in equal numbers from the capillary. However, when the capillary contained 0.1 mM nitrate, the wild type was recovered in significantly higher numbers than the tsr mutant (Fig. 2B and Table S1). Introduction of the cloned tsr gene (pFR6) into the tsr mutant resulted in increased recovery from a capillary containing 0.1 mM nitrate. Interestingly, the wild type was recovered in similar numbers as an aer mutant from a capillary containing 0.1 mM nitrate. However, Aer was able to mediate energy taxis towards higher concentrations of nitrate, because the wild type was recovered in significantly higher numbers than an aer mutant from a capillary containing 1 mM nitrate. Neither Aer nor Tsr mediated energy taxis towards nitrate when the assay was repeated under aerobic conditions. In conclusion, Tsr, but not Aer, functioned in mediating energy taxis towards low concentrations of nitrate in an anaerobic environment.
S. Typhimurium encodes three nitrate reductases, encoded by the narGHJI, narZYWV and napFDAGHBC operons. Inactivation of these three nitrate reductases in a napA narZ narG mutant abrogates the ability of S. Typhimurium to perform nitrate respiration [26]. A napA narZ narG mutant (CAL50) and a napA narZ narG tsr mutant (FR46) were recovered in similar numbers from a capillary containing 0.1 mM nitrate (Fig. 2B), suggesting that Tsr-mediated taxis towards nitrate required bacteria to perform nitrate respiration.
To investigate whether the fitness advantage conferred by the tsr gene was dependent on the ability of S. Typhimurium to perform nitrate respiration in vivo, we infected groups of streptomycin pre-treated mice with an equal mixture of a nitrate respiration-deficient mutant (napA narZ narG mutant, CAL50) and a napA narZ narG tsr mutant (FR46). The fitness advantage conferred by Tsr was abrogated during competition of the napA narZ narG mutant with the napA narZ narG tsr mutant (Fig. 1B). These data suggested that the ability of S. Typhimurium to utilize nitrate as an electron acceptor was required to see a benefit of Tsr during growth in the inflamed gut.
Energy taxis increases bacterial numbers in close proximity to the mucosal surface
Tetrathionate respiration has recently been shown to enhance growth of S. Typhimurium in bovine ligated ileal loops [18]. Since bacteria are recovered at a defined early time point (8 hours) after infection, we reasoned that this model would be well suited for chemotaxis experiments. The events leading to the formation of tetrathionate (i.e. the generation of thiosulfate by the colonic epithelium and the respiratory burst of transmigrating neutrophils) are expected to occur in close proximity to the epithelium. To investigate the benefit of tetrathionate respiration in different luminal compartments, we infected bovine ligated ileal loops with an equal mixture of an aer mutant (FR5) and a S. Typhimurium wild-type strain that was marked by a phoN::Kan insertion to facilitate recovery (AJB715) (competitive infection assay). Remarkably, higher numbers (P<0.05) of the wild-type strain (AJB715) were found in close association with tissue, while equal numbers of both strains were recovered from the luminal fluid 8 hours after infection (Fig. 3A). No benefit of energy taxis was observed when loops were infected with an equal mixture of an invA spiB mutant (SPN452) and an invA spiB aer mutant (FR11) (Fig. 3A). Measurements of fluid accumulation, a surrogate for the severity of intestinal inflammation [27], suggested that the severity of inflammatory changes was significantly (P<0.05) reduced in loops infected with a mixture of the invA spiB mutant and the invA spiB aer mutant compared to loops infected with a mixture of the wild type and aer mutant (Fig. 3B). The wild type (AJB715) was recovered in higher numbers than a tsr mutant (FR4) from tissue-associated samples, but not from the luminal fluid of loops infected with a mixture of both strains (Fig. 3A). We conclude that Tsr and Aer-mediated energy taxis increased bacterial numbers in spatial niches that were in close proximity to the inflamed mucosal surface.
Energy taxis boosts growth of S. Typhimurium in the inflamed intestine
Finally, to determine the consequences of energy taxis on bacterial growth after oral infection with individual strains, streptomycin pre-treated mice were inoculated with sterile LB broth (mock infection), the S. Typhimurium wild type (IR715), an aer mutant (FR5), a tsr mutant (FR4) or a chemotaxis-deficient mutant (cheY mutant, FR13) and organs were collected for analysis four days later. Mice infected with the S. Typhimurium wild type developed acute cecal inflammation (Fig. S5). There was a modest reduction in the severity of cecal inflammation in mice infected with an aer mutant or a cheY mutant, but the severity of lesions was similar in mice infected with the tsr mutant. Importantly, the aer mutant, the tsr mutant and the cheY mutant were recovered in significantly (P<0.05) reduced numbers from the colon contents of mice than wild-type S. Typhimurium (Fig. 4). Collectively, our data suggested that Tsr and Aer-mediated energy taxis towards electron acceptors generated by the host inflammatory response conferred a fitness advantage in the mouse colitis model (Fig. S6).
Discussion
Motility and chemotaxis confer a fitness advantage when S. Typhimurium resides in the lumen of the inflamed gut, but not during luminal growth in the non-inflamed intestine [6]. One important difference between the non-inflamed and the inflamed large bowel is that growth by anaerobic respiration becomes possible only in the latter niche [18], [26]. Changes in internal energetic conditions that accompany the switch from fermentative growth to growth by anaerobic respiration can be sensed by MCPs, which transduce this signal to the flagella apparatus to enable bacteria to approach spatial niches containing optimal concentrations of respiratory electron acceptors, a process termed energy taxis [22].
Colonic hydrogen sulfide produced by the fermenting microbiota is converted to thiosulfate by the colonic epithelium [16], [17]. During inflammation, neutrophils transmigrate into the intestinal lumen where they release ROS that oxidize thiosulfate to tetrathionate [18]. Furthermore, ROS can react with nitric oxide produced by iNOS to form the electron acceptor nitrate [28]. S. Typhimurium readily consumes these electron acceptors to boost its luminal growth in the inflamed gut [18], [26]. Tetrathionate and nitrate may be a limiting resource, requiring S. Typhimurium to actively seek out niches containing these electron acceptors. Here we show that energy taxis enhances the fitness of S. Typhimurium in the inflamed intestine, by enabling the pathogen to migrate towards favorable metabolic niches (Fig. S6).
While Aer and Tsr, both mediate energy taxis, our data suggest that the functions of these MCPs were not redundant in vivo. To migrate towards an anaerobic niche containing tetrathionate by Aer-mediated energy taxis, bacteria need to transfer electrons from NADH/H+ through the quinone pool onto the terminal electron acceptor tetrathionate (tetrathionate respiration), thereby altering the redox state of the cell. The flavin cofactor bound by Aer is proposed to sense changes in the redox state by becoming oxidized or reduced through interaction with a component of the electron transport chain, a process that generates the on and off signal for Aer-mediated energy taxis [21], [26]. Due to this mechanism, the ability to respire tetrathionate was essential for migrating towards higher concentrations of tetrathionate by energy taxis. S. Typhimurium strains that were unable to respire tetrathionate neither exhibited Aer-mediated energy taxis towards tetrathionate in vitro (Fig. 2) nor benefited from Aer-mediated energy taxis in vivo (Fig. 1). Collectively, these data implied that Aer mediates energy taxis towards spatial niches containing tetrathionate in the inflamed intestine.
In contrast, the competitive growth benefit conferred by Tsr did not require S. Typhimurium to respire tetrathionate (Fig. 1), indicating that Tsr does not mediate energy taxis towards this electron acceptor. Respiration of 1.3 mol of tetrathionate yields 1 mol of ATP [29], suggesting that tetrathionate respiration is not a strong generator of proton-motive force. This might explain why the proton-motive force sensor Tsr [20] did not mediate energy taxis towards tetrathionate. The nitrate/nitrite redox couple has a much higher standard redox potential (E° = 433 mV) [30] than the tetrathionate/thiosulfate redox couple (E° = 170 mV) [31] and nitrate reductases transport protons by scalar chemistry [24]. The fact that nitrate is a better generator of proton motive force might explain why Tsr sensed nitrate, but not tetrathionate. While Aer mediated energy taxis towards high concentrations of nitrate, only Tsr was functional when concentrations of nitrate were low. Our data show that in vivo Tsr-mediated energy taxis was nitrate respiration-dependent, while Aer-mediated energy taxis required tetrathionate respiration. Collectively, these observations suggest that concentrations of nitrate in the gut lumen of mice infected with S. Typhimurium are relatively low, thereby rendering Tsr the sole energy taxis sensor of nitrate in vivo.
Homologues of Aer have been characterized in E. coli [21], Vibrio cholerae [32], P. aeruginosa [33] and Campylobacter jejuni [34]. It has been proposed that energy taxis might be important in the upper gastrointestinal tract [22] where oxygen is a limiting parameter for growth [35]. Our work is the first to suggest that in the increasingly anaerobic environments of the terminal ileum and large bowel, energy taxis becomes important during conditions of intestinal inflammation, because ROS and RNS species generated during this response produce more favorable spatial niches containing respiratory electron acceptors. The ability to use energy taxis to migrate towards such favorable niches confers a growth benefit upon S. Typhimurium, and likely upon other facultative anaerobic bacteria.
It has been shown recently that nitrate generated as a by-product of the host inflammatory response supports a bloom of commensal E. coli by anaerobic respiration [28]. The picture emerging from this and previous studies [18], [26], [36] is that anaerobic respiration is one of the fundamental principles that boost growth of both commensal and pathogenic Enterobacteriaceae over the obligate anaerobic Clostridia and Bacteroidia during inflammation. The resulting outgrowth could lead to a competition between commensal Enterobacteriaceae and S. Typhimurium over nutrients, provided both microbes are present in the same animal. One factor important during the ensuing battle might be antimicrobial proteins, such as lipocalin-2. Lipocalin-2 is released into the intestinal lumen during inflammation [10] and prevents bacterial iron acquisition by binding enterobactin, a siderophore commonly produced by commensal Enterobacteriaceae [37], [38], [39]. The iroN iroBCDE gene cluster of S. enterica confers resistance to the antimicrobial protein lipocalin-2 and provides a growth advantage in the inflamed gut [10]. Lipocalin-2 resistance might confer an advantage upon S. enterica during its competition with commensal Enterobacteriaceae, provided that the latter rely on enterobactin for iron acquisition. However, additional work is needed to elucidate the mechanisms used by S. Typhimurium to compete with commensal Enterobacteriaceae in the lumen of the inflamed gut.
Materials and Methods
Bacterial strains and growth conditions
The bacterial strains used in this study are listed in Table 1. Unless indicated otherwise, bacteria were grown aerobically at 37°C in LB broth (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) or on LB agar plates (15 g/l agar). Antibiotics were added to the media at the following concentrations: 0.03 mg/ml chloramphenicol (Cm), 0.1 mg/ml carbenicillin (Carb), 0.05 mg/ml kanamycin (Kan), 0.05 mg/ml nalidixic acid (Nal), and 0.01 mg/ml tetracycline (Tet). When appropriate, the chromogenic substrate of the acidic phosphatase PhoN (5-Bromo-4-chloro-3-indolyl phosphate) was added to solid media at a concentration of 40 mg/l.
Table 1. Bacterial strains used in this study.
Strain | Genotype | Source/Reference |
S. Typhimurium strains | ||
ATCC 14028 | Wild-type isolate of S. enterica serotype Typhimurium | ATCC |
IR715 | Nalidixic acid-resistant derivative of ATCC 14028 | [44] |
AJB715 | IR715 ΔphoN::KanR | [45] |
AT350 | cheY::Tn10 (TetR) | [46] |
FR4 | IR715 tsr::pFR3 (CmR) | This Study |
FR5 | IR715 aer::pFR2 (CarbR) | This Study |
FR6 | IR715 aer::pFR2 tsr::pFR3 (CarbR, CmR) | This Study |
FR7 | IR715 aer::pFR4 (CmR) | This Study |
FR8 | IR715 ttrA::pSW171 tsr::pFR3 (CarbR, CmR) | This Study |
FR9 | IR715 ttrA::pSW171 aer::pFR4 (CarbR, CmR) | This Study |
FR10 | IR715 ΔinvA::tetRA ΔspiB::KSAC tsr::pFR3 (TetR, KanR, CmR) | This Study |
FR11 | IR715 ΔinvA::tetRA ΔspiB::KSAC aer::pFR2 (TetR, KanR, CarbR) | This Study |
FR13 | IR715 cheY::Tn10 (TetR) | This Study |
FR35 | IR715 mcpC::CmR | This Study |
FR36 | IR715 mcpB::KanR | This Study |
FR37 | IR715 mcpA::KanR | This Study |
FR38 | IR715 Δaer | This Study |
FR42 | IR715 trg::CmR | This Study |
FR43 | IR715 ΔinvA ΔspiB trg::CmR | This Study |
FR46 | IR715 tsr::pFR3 (CmR) ΔnapA ΔnarZ narG::pCAL5 | This Study |
FR47 | IR715 aerS22F | This Study |
CAL50 | IR715 ΔnapA ΔnarZ narG::pCAL5 | [26] |
MB193 | 14028 mcpA::KanR | This Study |
QW111 | 14028 mcpB::KanR | This Study |
SM15 | 14028 trg::CmR | This Study |
SM19 | 14028 mcpC::CmR | This Study |
SPN452 | IR715 ΔinvA::tetRA ΔspiB::KSAC (TetR; KanR) | [10] |
SPN453 | IR715 ΔinvA::KSAC (KanR) | This Study |
SPN455 | IR715 ΔinvA (unmarked deletion) | This Study |
SPN458 | IR715 ΔspiB::pSPN56(CmR, TetR, ΔspiB) | [30] |
SPN487 | IR715 ΔinvA ΔspiB (unmarked deletions) | This Study |
SW215 | IR715 flgK5396::MudJ | [47] |
SW661 | IR715 ttrA::pSW171 (CarbR) | [18] |
E. coli strains | ||
DH5α λpir | F− endA1 hsdR17 (r− m+) supE44 thi-1 recA1 gyrA96 relA1 Δ(lacZYA-argF)U169 deoR nupG Φ80lacZΔM15 λpir | [48] |
S17-1 λpir | zxx::RP4-2-Tetr::Mu-Kanr::Tn7 recA1 thi pro hsdR (r− m+) λpir | [49] |
TOP10 | F− mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 lacX74 recA1 araD139 Δ(ara - leu)7697 galE15 galK rpsL endA1 nupG | Invitrogen |
CmR: chloramphenicol resistance; CarbR: carbenicillin resistance; KanR: kanamycin resistance, TetR: tetracycline resistance.
To determine competitive indices (CI) after in vitro growth, LB broth or LB broth containing either 10 mM tetrathionate or 10 mM nitrate was inoculated with an equal mixture of two bacterial strains (at a density corresponding to a 1∶200 dilution of an overnight culture) and grown anaerobically at 37°C (Bactron I anaerobic chamber; Sheldon Manufacturing) overnight. The cultures were spread on agar plates containing the appropriate antibiotics to determine the ratio of recovered bacteria. Three technical replicates were performed for each experiment and each experiment was repeated at least three times independently.
Construction of plasmids
The plasmids and primers used in this study are listed in Tables 2 and 3, respectively. PCR products were routinely cloned into pCR2.1 using the TOPO TA cloning kit (Invitrogen, Carlsbad) and sequenced (SeqWright Fisher Scientific, Houston) prior to subcloning into appropriate vectors.
Table 2. Plasmids used in this study.
Designation | Relevant Characteristics | Reference/source |
pBS34 | pBluescript II KS+ (CarbR, KanR, KSAC cassette) | [10] |
pCR2.1 | Cloning vector; CarbR, KanR | Invitrogen |
pEP185.2 | oriR6K mobRP4 cat (CmR) | [50] |
pFR2 | ‘aer’ gene fragment cloned into pGP704; insertion of pFR2 into the IR715 chromosome aer gene. | This Study |
pFR3 | ‘tsr’ gene fragment cloned into pEP185.2; insertion of pFR3 into the IR715 chromosome disrupts tsr. | This Study |
pFR4 | ‘aer’ gene fragment cloned into pEP185.2; insertion of pFR4 into the IR715 chromosome disrupts aer. | This Study |
pFR5 | aer open reading frame and promoter cloned into pWSK29 | This Study |
pFR6 | tsr open reading frame and promoter cloned into pWSK29 | This Study |
pKD3 | oriR6K, CmR | [42] |
pKD4 | oriR6K, KanR | [42] |
pKD46 | Plasmid encoding lambda red recombinase | [42] |
pSPN57 | pRDH10(CmR, ΔinvA(−9 to +2057)) | [10] |
pSPN60 | pSPN57(CmR, KanR, ΔinvA::KSAC) | This Study |
pWSK29 | Cloning vector; CarbR | [51] |
pWSK129 | Cloning vector; KanR | [51] |
Table 3. Primers used in this study.
Target gene (purpose)/organism | Sequence |
aer (cloning)/S. Typhimurium | 5′-GTCGACCGGACTCCGCCATCTGG-3′ |
5′-GAGCTCCTATTGGAATGGCAAATTGTGC-3′ | |
aer (complementation)/S. Typhimurium | 5′-TCTAGATTTAGCGTTCGCTTCTCGAT-3′ |
5′-GAGCTCCCTTCTATCAGAGCGCATCC-3′ | |
aer (RT PCR)/S. Typhimurium | 5′-CACGGTTCGCCCTGTTTTAG-3′ |
5′- CTCACGCCAATGACACTTTTG-3′ | |
aer (deletion)/S. Typhimurium | del_A 5′-GTCGACTGAATTAAGTATTGCAGGGATTAGC-3′ |
del_B 5′-TGACCGCATCAGAAGACATGATAGCGTCCTGTG-3′ | |
del_C 5′-CATGTCTTCTGATGCGGTCACGGTACTGC-3′ | |
del_D 5′-GGATCCTTTCACCGTGGTGGGATAAT-3′ | |
aer (point mutant)/S. Typhimurium | S22F_B 5′-GGTCGTAAACATCAGAGTGGTATC-3′ |
S22F_C 5′-GATGTTTACGACCGACCTGG-3′ | |
gmk (RT PCR)/S. Typhimurium | 5′-TTGGCAGGGAGGCGTTT-3′ |
5′-GCGCGAAGTGCCGTAGTAAT-3′ | |
invA (deletion presence)/S. Typhimurium | 5′-TTCGTCGTAAAGACCTGG-3′ |
5′-GGTAATCAGCGGTTCACG-3′ | |
invA (gene presence)/S. Typhimurium | 5′-CTTTACGGTTCCTTTGACG-3′ |
5′-ATTACGCACGGAAACACG-3′ | |
KSAC (outwards cassette primers)/S. Typhimurium | 5′-GGCATAAATTCCGTCAGC-3′ |
5′-TGATGACGAGCGTAATGG-3′ | |
mcpA (cloning)/S. Typhimurium | 5′-AATGTTGTCAAAATACCGCCGCCAGCAGCAGAATCTGGCGTGTAGGCTGGAGCTGCTTC-3′ |
5′-TTCCAGCTGGTTAACCACCTCATTACTGGATCGCTCCATATATGAATATCCTCCTTAGT-3′ | |
mcpB (cloning)/S. Typhimurium | 5′-CTAATCTCTTATATTCAGCAAGGAAATTCATATGCGTTTGGTGTAGGCTGGAGCTGCTTC-3′ |
5′-GCCAGCGCATTACGCGCTTTTTTGCTTCACATCAGAAGGAACATATGAATATCCTCCTTAG-3′ | |
mcpC (cloning)/S. Typhimurium | 5′-GTTTTTGCATAACATTAAAATACGTTCAAAATTATTTATGGTGTAGGCTGGAGCTGCTTC-3′ |
5′-CCTCTTCGCGGACGCGGAACACGTTAACCAGCTCTTTTAACATATGAATATCCTCCTTAG -3′ | |
mcpC (RT PCR)/S. Typhimurium | 5′-AGAGAGTTTGGTCGCTTCAC-3′ |
5′-ATGGAACAGATTACCGCCAC-3′ | |
spiB (deletion presence)/S. Typhimurium | 5′-GGGTCGTTAGTGTATTGC-3′ |
5′-CTGTTGACTCACCTTAGC-3′ | |
spiB (gene presence)/S. Typhimurium | 5′-TGGCTGAATGAAGGTAACC-3′ |
5′-CTCAGATGGACAATTTCTCC-3′ | |
trg (cloning)/S. Typhimurium | 5′-TATTCGGCTGGTTCCGCTGTTTTCCTCCATTCTCGGTGGCGTGTAGGCTGGAGCTGCTTC-3′ |
5′-AGCGGGCAGCCTGTTCTTCAAGCGAACGTGCCGCCGCGGACATATGAATATCCTCCTTAG-3′ | |
tsr (cloning)/S. Typhimurium | 5′-CGTCGACTACGATATTGCTGTTGAGG-3′ |
5′-GAGCTCATCGTTGTTGCCCATCG-3′ | |
Gapdh (RT PCR)/Mus musculus | 5′-TGTAGACCATGTAGTTGAGGTCA-3′ |
5′-AGGTCGGTGTGAACGGATTTG-3′ | |
Kc (RT PCR)/Mus musculus | 5′-TGCACCCAAACCGAAGTCAT-3′ |
5′-TTGTCAGAAGCCAGCGTTCAC-3′ | |
Nos2 (RT PCR)/Mus musculus | 5′-CCAGCCTTGCATCCTCATTGG-3′ |
5′-CCAAACACCAAGCTCATGCGG-3′ |
RT PCR, quantitative real-time PCR.
An internal fragment of the aer gene was amplified by PCR using the primers listed in Table 3. The aer PCR product was then cloned into the suicide plasmids pGP704 and pEP185.2 using the SalI and SacI restriction enzyme sites to construct pFR2 and pFR4, respectively. A fragment of the tsr gene was amplified by PCR and subcloned into pEP185.2 using the SalI and SacI restriction enzyme sites to create pFR3. The KSAC kanamycin resistance cassette of pBS34 was subcloned into the XbaI restriction site of pSPN57, generating a Kan-marked allelic exchange invA deletion construct (pSPN60).
A suicide plasmid for generating a deletion of the aer gene was constructed by using primers del_A and del_B to PCR amplify a 404 bp 5′ flanking sequence that included 9 nucleotides of the aer coding region. Primers del_C and del_D were used to PCR amplify a 573 bp fragment that included 24 nucleotides of the 3′ coding region. The two PCR fragments were joined using the splicing overlap extension (SOE) technique [40], [41] and the resulting PCR product containing an in-frame aer deletion was digested with BamHI and SalI and cloned into pRDH10 to generate plasmid pFR7.
A suicide plasmid for introducing a point mutation into the aer open reading frame was constructed by PCR amplifying a 5′ fragment of the aer gene using primer del_A, which anneals 395 bps upstream of the gene and primer S22F_B, which contains a missense mutation (C65T). Primer S22F_C, which encodes the same missense mutation and primer del_D were used to amplify the remaining aer ORF plus 549 bps downstream of the aer stop codon. The two PCR fragments were joined using the SOE technique [40], [41] and the resulting PCR product containing an aer allele with a C65T substitution was digested with BamHI and SalI and cloned into pRDH10 to generate pFR8.
For complementation of the aer mutant, the aer open reading frame including the promoter region was amplified using the primers listed in Table 3. The resulting PCR fragment was cloned into pWSK29 using XbaI and SacI to create pFR5.
For complementation of the tsr mutant, the tsr open reading frame including the promoter region was amplified using the primers listed in Table 3. The resulting PCR fragment was cloned into pWSK29 using XbaI and SacI to create pFR6.
Construction of S. Typhimurium mutants by allelic exchange
Suicide plasmids were propagated in E. coli DH5α λpir and introduced into the S. Typhimurium strain IR715 by conjugation using E. coli S17-1 λpir as a donor strain. Transconjugants were selected on LB plates containing nalidixic acid (IR715) and antibiotics selecting for integration of the suicide plasmid. Integration of the suicide plasmids was verified by PCR. Using this methodology, pFR2, pFR4 and pFR3 were integrated into the aer and tsr genes of IR715 to yield strains FR5, FR7 and FR4, respectively. An mcpA mutant (MB193) mcpB mutant (QW111), mcpC mutant (SM19) and trg mutant (SM15) were constructed by the one-step mutagenesis method [42]. Primers were designed with overhang sequences complementarily to the beginning and end of the Cm cassette in pKD3 to replace most of the mcpC gene or the trg gene with a Cm cassette, generating SM19 and SM15, respectively. Primers were designed with overhang sequences complementarily to the beginning and end of Kan cassette in pKD4 to replace most of the mcpA or mcpB open reading frames with a Kan cassette to generate strains MB193 and QW111, respectively.
The invA locus of IR715 was deleted with the KSAC Kan resistance cassette by conjugating pSPN60 from S17-1 λpir into IR715, selecting for double-crossover transconjugants on LB plates containing Nal and Kan. A strain positive for amplification with primers directed outwards from KSAC and primers directed inwards from beyond the flanking regions employed in the deletion of invA was labeled SPN453. An unmarked invA deletion mutant was then generated by conjugating pSPN57 from S17-1 λpir into SPN453 by following a previously described methodology [30]. A strain positive by PCR for the unmarked invA deletion and negative for invA amplification was termed SPN455.
The aer was deleted by conjugation of pFR7 from E. coli S17-1 λpir into S. Typhimurium strain IR715. Transconjugants were selected for on LB plates containing Nal and Cm. Sucrose counter-selection was performed as described previously [43]. A strain that was sucrose-tolerant and Cms was verified by PCR to carry a deletion in aer and was denoted FR38.
The aer S22F mutation was constructed by conjugation of pFR8 from E. coli S17-1 λpir into S. Typhimurium strain FR38. Transconjugants were selected for on LB plates containing Nal and Cm. Sucrose counter-selection was performed as described previously [43]. A strain that was sucrose-tolerant and Cms, denoted FR47, was verified by PCR amplification and sequence analysis.
Generalized phage transduction
Phage P22 HT105/1 int-201 was used for generalized transduction. Transductants were routinely purified from phage contamination on Evans blue-Uranine agar and then cross-struck against P22 H5 to confirm phage sensitivity. The ttrA::pSW171 mutation from SW661 was introduced into FR4 and FR7 to yield strains FR8 and FR9, respectively. The tsr::pFR3 or aer::pFR2 mutations were introduced into the SPN452 to create strains FR10 and FR11, respectively. The cheY::Tn10 mutation from AT350 was transduced into IR715 to generate strain FR13. The mcpC::Cm mutation from SM19 was transduced into IR715 to generate FR35. The mcpB::Kan mutation from QW111 was transduced into IR715 to generate FR36. The mcpA::Kan mutation from MB193 was transduced into IR715 to generate FR37.The trg::Cm mutation from SM15 was transduced into IR715 to generate FR42.
An unmarked spiB deletion was generated in SPN455 by transducing the merodiploid ΔspiB::pSPN56(ΔspiB) locus from SPN458 followed by sucrose selection as previously described [30]. A strain positive by PCR for the unmarked spiB deletion and negative for spiB amplification was dubbed SPN487. The trg::Cm mutation of SM15 was then transduced into SPN487, creating FR43.
Animal experiments
Mouse and calf experiments adhered to USDA guidelines and were approved by the Institutional Animal Care and Use Committees at the University of California at Davis and Texas A&M University, respectively.
Mouse colitis model
Female C57BL/6J mice, aged 9–12 weeks, were obtained from The Jackson Laboratory (Bar Harbor). Animals were pretreated with 20 mg Streptomycin and orally inoculated 24 hours later with 0.1 ml LB broth or S. Typhimurium in 0.1 ml LB broth as described previously [11]. For competitive infections, mice were inoculated with an equal mixture of 5×108 CFU of each strain. For single strain infections, animals were inoculated with approximately 1×109 CFU per animal. Animals were euthanized 4 days after infection and organs were collected for RNA purification and bacteriological analysis as described previously [18]. For competitive infections, the ratio of recovered wild-type bacteria to mutant bacteria (output ratio) was divided by the ratio present in the inoculum (input ratio) to determine the competitive index (CI).
Mouse typhoid model
Female CBA/J mice, aged 6–8 weeks, were obtained from The Jackson Laboratory (Bar Harbor). Animals were inoculated with 0.1 ml of a suspension (LB broth) containing an equal mixture of 5×108 CFU of each bacterial strain. Animals were euthanized at the indicated time points to collect organs.
Bovine ligated ileal loop model
Bovine ligated ileal loops surgery was performed as described previously [27]. Briefly, bovine loops were infected by intralumenal injection of 3 ml of a suspension of bacterial strains in LB broth containing an equal mixture of 5×108 CFU of each strain as indicated. 8 h after infection, loops were resected and luminal contents collected. Loops were opened longitudinally and 6 mm tissue biopsy punches were collected, and the homogenized tissue spread on selective media. Each bacterial strain was tested in at least three different animals. To facilitate recovery of Salmonella strains from biological samples, the wild-type strain (IR715) was marked with a mutation in the phoN gene (AJB715).
Motility plate assay
Soft agar motility plates containing LB and 0.3% (w/v) agar or soft agar plates supplemented with 5 mM tetrathionate were inoculated with single colonies and incubated at 37°C anaerobically (GasPak system, BD Biosciences) for 6.5 hours and the area of the halo was determined (Labworks 4.6 software, UVP). Each experiment was performed in triplicate.
Capillary assay
Capillary assays were performed as described previously [23] with the modifications indicated below. An overnight culture was diluted 1∶100 in LB broth and grown anaerobically at 37°C (Bactron I anaerobic chamber; Sheldon Manufacturing) to late exponential phase (OD600 between 0.6–0.8). An equal volume of each strain was added to a tube and washed twice (3,220 g, 5 minutes) in 0.5 ml of chemotaxis buffer (CB; 10 mM potassium phosphate buffer (pH 7.4), 0.1 mM EDTA). The pellet was resuspended in CB to a concentration of between 1×107 and 1×108 CFU/ml and 100 µl of the culture was added to a 1.5 ml tube. To make the capillaries, 1 µl glass capillaries that had been sealed on one end were briefly flamed and then added to 1.5 ml microcentrifuge tubes containing tetrathionate or nitrate at the indicated concentrations. The glass capillary was then placed into a 1.5 ml microcentrifuge tube containing S. Typhimurium strains and incubated at 37°C inside the anaerobe chamber for 45 minutes. The glass capillary was removed, and wiped off and dilutions of the contents of the capillary tube were spread on agar plates containing the appropriate antibiotics. Three technical replicates were performed for each experiment and each experiment was repeated at least three times independently.
RT-PCR and real time PCR analysis
Eukaryotic gene expression was determined by real-time PCR as previously described [18]. Briefly, eukaryotic RNA was isolated using TRI reagent (Molecular Research Center, Cincinnati). A Reverse transcriptase reaction was performed to prepare complementary DNA (cDNA) using TaqMan reverse transcription reagents (Applied Biosystems, Carlsbad). A volume of 4 µl of cDNA was used as template for each real-time PCR reaction in a total reaction volume of 25 µl. Real-time PCR was performed using SYBR-Green (Applied Biosystems) along with the primers listed in Table 3. Data were analyzed using the comparative Ct method (Applied Biosystems). Transcript levels of Nos2 and Kc were normalized to mRNA levels of the housekeeping gene Gapdh.
Bacterial gene expression
Bacterial RNA was isolated using the Aurum Total RNA Kit (Bio-Rad) according to the recommendations of the manufacturer. Afterward, an additional DNase treatment was performed using the Ambion DNA removal and inactivation kit. RT-PCR and real-time PCR were performed as described previously [36]. Transcription of the mcpC in each sample was normalized to the respective levels of guanyl nucleotide kinase mRNA, encoded by the gmk gene.
Histopathology
Formalin fixed cecal tissue sections were stained with hematoxylin and eosin, and a veterinary pathologist performed a blinded evaluation using criteria published previously [36]. Representative images were obtained using an Olympus BX41 microscope and the brightness adjusted (Adobe Photoshop CS2).
Statistical analysis
Fold changes of ratios (bacterial numbers or mRNA levels) were transformed logarithmically prior to statistical analysis. An unpaired Student's t-test was used to determine whether differences in fold changes between groups were statistically significant (P<0.05). Significance of differences in histopathology scores was determined by a one-tailed non-parametric test (Mann-Whitney).
Supporting Information
Funding Statement
We would like to acknowledge support by Public Health Service Grants AI088122 and AI096528 to AJB and AI076246 to AJB, CLB and LGA. CAL was supported by Public Health Service Grant AI060555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Tsolis RM, Adams LG, Ficht TA, Baumler AJ (1999) Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect Immun 67: 4879–4885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, et al. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5: 2177–2189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Barman M, Unold D, Shifley K, Amir E, Hung K, et al. (2008) Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76: 907–915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, et al. (2008) Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 76: 403–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Stecher B, Hapfelmeier S, Muller C, Kremer M, Stallmach T, et al. (2004) Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72: 4138–4150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Stecher B, Barthel M, Schlumberger MC, Haberli L, Rabsch W, et al. (2008) Motility allows S. Typhimurium to benefit from the mucosal defence. Cell Microbiol 10: 1166–1180. [DOI] [PubMed] [Google Scholar]
- 7. Kondoh H, Ball CB, Adler J (1979) Identification of a methyl-accepting chemotaxis protein for the ribose and galactose chemoreceptors of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 76: 260–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hazelbauer GL, Harayama S (1979) Mutants in transmission of chemotactic signals from two independent receptors of E. coli. Cell 16: 617–625. [DOI] [PubMed] [Google Scholar]
- 9. Harayama S, Palva ET, Hazelbauer GL (1979) Transposon-insertion mutants of Escherichia coli K12 defective in a component common to galactose and ribose chemotaxis. Molecular & general genetics : MGG 171: 193–203. [DOI] [PubMed] [Google Scholar]
- 10. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, et al. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5: 476–486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839–2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Tsolis RM, Xavier MN, Santos RL, Baumler AJ (2011) How to become a top model: impact of animal experimentation on human Salmonella disease research. Infection and immunity 79: 1806–1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Frye J, Karlinsey JE, Felise HR, Marzolf B, Dowidar N, et al. (2006) Identification of new flagellar genes of Salmonella enterica serovar Typhimurium. Journal of bacteriology 188: 2233–2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Wang Q, Mariconda S, Suzuki A, McClelland M, Harshey RM (2006) Uncovering a large set of genes that affect surface motility in Salmonella enterica serovar Typhimurium. Journal of bacteriology 188: 7981–7984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Sekirov I, Gill N, Jogova M, Tam N, Robertson M, et al. (2010) Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota. Gut microbes 1: 30–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Furne J, Springfield J, Koenig T, DeMaster E, Levitt MD (2001) Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem Pharmacol 62: 255–259. [DOI] [PubMed] [Google Scholar]
- 17. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E (1999) Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 104: 1107–1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, et al. (2010) Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Hensel M, Hinsley AP, Nikolaus T, Sawers G, Berks BC (1999) The genetic basis of tetrathionate respiration in Salmonella typhimurium. Mol Microbiol 32: 275–287. [DOI] [PubMed] [Google Scholar]
- 20. Edwards JC, Johnson MS, Taylor BL (2006) Differentiation between electron transport sensing and proton motive force sensing by the Aer and Tsr receptors for aerotaxis. Mol Microbiol 62: 823–837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Greer-Phillips SE, Alexandre G, Taylor BL, Zhulin IB (2003) Aer and Tsr guide Escherichia coli in spatial gradients of oxidizable substrates. Microbiology 149: 2661–2667. [DOI] [PubMed] [Google Scholar]
- 22. Schweinitzer T, Josenhans C (2010) Bacterial energy taxis: a global strategy? Arch Microbiol 192: 507–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Alder J (1974) Chemoreception in bacteria. Antibiotics and chemotherapy 19: 12–20. [PubMed] [Google Scholar]
- 24.Gennis RB, Stewart V (1996) Respiration. In: Neidhardt FC, Curtiss III R, Ingraham JL, Lin ECC, Low KB, et al.., editors. Escherichia coli and Salmonella Cellular and Molecular Biology. 2nd edition. Washington, D.C.: ASM Press. pp. 217–261. [Google Scholar]
- 25. Bibikov SI, Barnes LA, Gitin Y, Parkinson JS (2000) Domain organization and flavin adenine dinucleotide-binding determinants in the aerotaxis signal transducer Aer of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 97: 5830–5835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Lopez CA, Winter SE, Rivera-Chavez F, Xavier MN, Poon V, et al. (2012) Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration. mBio 3: e00143–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Santos RL, Tsolis RM, Zhang S, Ficht TA, Baumler AJ, et al. (2001) Salmonella-induced cell death is not required for enteritis in calves. Infect Immun 69: 4610–4617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, et al.. (2013) Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science: In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Kaprálek F (1972) The physiological role of tetrathionate respiration in growing citrobacter. J Gen Microbiol 71: 133–139. [DOI] [PubMed] [Google Scholar]
- 30. Thauer RK, Jungermann K, Decker K (1977) Energy conservation in chemotrophic anaerobic bacteria. Bacteriological reviews 41: 100–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Kapralek F (1972) The physiological role of tetrathionate respiration in growing citrobacter. Journal of general microbiology 71: 133–139. [DOI] [PubMed] [Google Scholar]
- 32. Boin MA, Hase CC (2007) Characterization of Vibrio cholerae aerotaxis. FEMS microbiology letters 276: 193–201. [DOI] [PubMed] [Google Scholar]
- 33. Hong CS, Kuroda A, Ikeda T, Takiguchi N, Ohtake H, et al. (2004) The aerotaxis transducer gene aer, but not aer-2, is transcriptionally regulated by the anaerobic regulator ANR in Pseudomonas aeruginosa. Journal of bioscience and bioengineering 97: 184–190. [DOI] [PubMed] [Google Scholar]
- 34. Hendrixson DR, Akerley BJ, DiRita VJ (2001) Transposon mutagenesis of Campylobacter jejuni identifies a bipartite energy taxis system required for motility. Molecular microbiology 40: 214–224. [DOI] [PubMed] [Google Scholar]
- 35. Horne SM, Mattson KR, Pruss BM (2009) An Escherichia coli aer mutant exhibits a reduced ability to colonize the streptomycin-treated mouse large intestine. Antonie van Leeuwenhoek 95: 149–158. [DOI] [PubMed] [Google Scholar]
- 36. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, et al. (2011) Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proceedings of the National Academy of Sciences of the United States of America 108: 17480–17485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, et al. (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033–1043. [DOI] [PubMed] [Google Scholar]
- 38. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, et al. (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103: 1834–1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, et al. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917–921. [DOI] [PubMed] [Google Scholar]
- 40. Lefebvre B, Formstecher P, Lefebvre P (1995) Improvement of the gene splicing overlap (SOE) method. BioTechniques 19: 186–188. [PubMed] [Google Scholar]
- 41. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z, et al. (1993) Gene splicing by overlap extension. Methods in enzymology 217: 270–279. [DOI] [PubMed] [Google Scholar]
- 42. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Lawes M, Maloy S (1995) MudSacI, a transposon with strong selectable and counterselectable markers: use for rapid mapping of chromosomal mutations in Salmonella typhimurium. Journal of bacteriology 177: 1383–1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Stojiljkovic I, Baumler AJ, Heffron F (1995) Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. J Bacteriol 177: 1357–1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Kingsley RA, Humphries AD, Weening EH, De Zoete MR, Winter S, et al. (2003) Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants. Infect Immun 71: 629–640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Mariconda S, Wang Q, Harshey RM (2006) A mechanical role for the chemotaxis system in swarming motility. Molecular microbiology 60: 1590–1602. [DOI] [PubMed] [Google Scholar]
- 47. Winter SE, Thiennimitr P, Nuccio SP, Haneda T, Winter MG, et al. (2009) Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection. Infect Immun 77: 1904–1916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Grant SGN, Jessee J, Bloom FR, Hanahan D (1990) Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci USA 87: 4645–4649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Simon R, Priefer U, Puhler A (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Bio/Technology 1: 784–791. [Google Scholar]
- 50. Kinder SA, Badger JL, Bryant GO, Pepe JC, Miller VL (1993) Cloning of the YenI restriction endonuclease and methyltransferase from Yersinia enterocolitica serotype O:8 and construction of a transformable R-M+ mutant. Gene 136: 271–275. [DOI] [PubMed] [Google Scholar]
- 51. Wang RF, Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100: 195–199. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.